<p>StockNews.com 在週五發佈的研究報告中開始覆蓋 Walgreens Boots Alliance (NASDAQ:WBA - 獲取免費報告) 的股票。該公司對這家藥房運營商的股票設定了 “持有” 評級。</p>
<ul>
<li>Walgreens 復甦？私募股權公司正在尋求收購</li>
</ul>
<p>其他幾位股票研究分析師也對 WBA 發表了看法。Truist Financial 將 Walgreens Boots Alliance 的目標價從 13.00 美元下調至 12.00 美元，並在 1 月 31 日的報告中對該公司設定了 “持有” 評級。德意志銀行將 Walgreens Boots Alliance 的股票評級從 “持有” 下調至 “賣出”，並在 2 月 28 日的研究報告中將該公司的目標價從 11.00 美元下調至 9.00 美元。加拿大皇家銀行將 Walgreens Boots Alliance 的目標價從 9.00 美元上調至 12.00 美元，並在 1 月 15 日的報告中給予該股票 “行業表現” 評級。Wolfe Research 在 2 月 24 日的研究報告中將 Walgreens Boots Alliance 的股票評級上調至 “持有”。最後，美國銀行在 1 月 13 日的報告中將 Walgreens Boots Alliance 的目標價從 7.50 美元上調至 8.50 美元，並給予該股票 “表現不佳” 評級。四位股票研究分析師對該股票給予了 “賣出” 評級，七位給予了 “持有” 評級，二位給予了 “買入” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 10.59 美元。</p>
<p><strong>獲取我們關於 Walgreens Boots Alliance 的最新報告</strong></p>
<h2>Walgreens Boots Alliance 價格表現</h2>
<ul>
<li>MarketBeat 週迴顧 – 03/10 - 03/14</li>
</ul>
<p>WBA 週五開盤價為 10.69 美元。該公司的 50 日移動平均價格為 10.73 美元，200 日移動平均價格為 10.05 美元。該公司的市值為 92.4 億美元，市盈率為 -1.04，市盈增長比率為 1.31，貝塔值為 0.67。該公司的債務與股本比率為 0.68，流動比率為 0.64，速動比率為 0.30。Walgreens Boots Alliance 的一年低點為 8.08 美元，一年高點為 18.83 美元。</p>
<p>Walgreens Boots Alliance (NASDAQ:WBA - 獲取免費報告) 最近在 4 月 8 日發佈了季度財報。該藥房運營商報告季度每股收益為 0.63 美元，超出分析師共識預期的 0.53 美元，超出幅度為 0.10 美元。Walgreens Boots Alliance 的股本回報率為 17.61%，淨利潤率為 -5.87%。該公司本季度的收入為 385.9 億美元，而分析師預期為 379.0 億美元。去年同期，該公司每股收益為 1.20 美元。Walgreens Boots Alliance 本季度的收入較去年同期增長了 4.1%。整體來看，分析師預計 Walgreens Boots Alliance 在當前財政年度的每股收益為 1.6 美元。</p>
<h2>機構資金流入和流出</h2>
<ul>
<li>Walgreens Boots Alliance：不要輕易放棄這個資產冠軍</li>
</ul>
<p>一些機構投資者和對沖基金最近調整了對該股票的持有。Sentry Investment Management LLC 在第一季度購買了 Walgreens Boots Alliance 的新頭寸，價值約 27,000 美元。First Financial Corp IN 在第四季度將其在 Walgreens Boots Alliance 的持有量增加了 49.2%。First Financial Corp IN 目前擁有 2,685 股該藥房運營商的股票，價值 25,000 美元，此前在上個季度增持了 885 股。Golden State Wealth Management LLC 在第四季度購買了 Walgreens Boots Alliance 的新頭寸，價值約 26,000 美元。Riverview Trust Co 在第四季度將其在 Walgreens Boots Alliance 的持股增加了 123.8%。Riverview Trust Co 目前擁有 2,874 股該藥房運營商的股票，價值 27,000 美元，此前在上個季度增持了 1,590 股。最後，Colonial Trust Co SC 在第四季度將其在 Walgreens Boots Alliance 的持有量增加了 79.5%。Colonial Trust Co SC 目前擁有 2,928 股該藥房運營商的股票，價值 27,000 美元，此前在此期間增持了 1,297 股。58.59% 的股票由機構投資者持有。</p>
<h2>關於 Walgreens Boots Alliance</h2>
<p>(獲取免費報告)</p>
<p>Walgreens Boots Alliance, Inc 在美國、英國、德國及國際上運營，作為一家醫療、藥房和零售公司。它通過三個部門運營：美國零售藥房、國際和美國醫療。美國零售藥房部門從事零售藥店、健康和保健服務、專業和家庭配送藥房服務的運營，提供健康和保健、美容、個人護理和消費品以及一般商品。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Walgreens Boots Alliance</li>
<li>現在購買的 3 只沃倫·巴菲特股票</li>
<li>Joby Aviation：運營勢頭與市場情緒的對比</li>
<li>技術指標如何幫助你找到被低估的股票</li>
<li>博通的強勁表現顯示出關税下降中的韌性</li>
<li>找到並盈利交易 52 周低點的股票</li>
<li>Carvana：能否逆轉強勁的市場逆風？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Walgreens Boots Alliance 嗎？</h2>
<p>在你考慮 Walgreens Boots Alliance 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而沃爾格林聯合博姿並不在名單上。</p>
<p>雖然沃爾格林聯合博姿目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

沃爾格林聯合博姿

<p>StockNews.com 已對沃爾格林聯合博姿（NASDAQ:WBA）啓動了覆蓋，給予 “持有” 評級。分析師們的意見不一，Truist Financial 將其目標價從 13.00 美元下調至 12.00 美元，而德意志銀行則將評級從 “持有” 下調至 “賣出”，目標價為 9.00 美元。該股票的平均評級為 “持有”，目標價為 10.59 美元。沃爾格林報告的季度每股收益為 0.63 美元，超出預期，收入為 385.9 億美元，同比增長 4.1%。機構投資者持有該股票的 58.59%</p>

<p>StockNews.com began coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) in a research note issued on Friday. The firm set a &#34;hold&#34; rating on the pharmacy operator's stock.</p>
<div class="lb-trans"><p>StockNews.com 在週五發佈的研究報告中開始覆蓋 Walgreens Boots Alliance (NASDAQ:WBA - 獲取免費報告) 的股票。該公司對這家藥房運營商的股票設定了 “持有” 評級。</p>
</div><ul>
<li>Walgreens Comeback? Private Equity Circling for a Buyout</li>
</ul>
<div class="lb-trans"><ul>
<li>Walgreens 復甦？私募股權公司正在尋求收購</li>
</ul>
</div><p>Several other equities research analysts have also weighed in on WBA. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a &#34;hold&#34; rating for the company in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a &#34;hold&#34; rating to a &#34;sell&#34; rating and lowered their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a &#34;sector perform&#34; rating in a report on Wednesday, January 15th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a &#34;hold&#34; rating in a research note on Monday, February 24th. Finally, Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an &#34;underperform&#34; rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of &#34;Hold&#34; and an average price target of $10.59.</p>
<div class="lb-trans"><p>其他幾位股票研究分析師也對 WBA 發表了看法。Truist Financial 將 Walgreens Boots Alliance 的目標價從 13.00 美元下調至 12.00 美元，並在 1 月 31 日的報告中對該公司設定了 “持有” 評級。德意志銀行將 Walgreens Boots Alliance 的股票評級從 “持有” 下調至 “賣出”，並在 2 月 28 日的研究報告中將該公司的目標價從 11.00 美元下調至 9.00 美元。加拿大皇家銀行將 Walgreens Boots Alliance 的目標價從 9.00 美元上調至 12.00 美元，並在 1 月 15 日的報告中給予該股票 “行業表現” 評級。Wolfe Research 在 2 月 24 日的研究報告中將 Walgreens Boots Alliance 的股票評級上調至 “持有”。最後，美國銀行在 1 月 13 日的報告中將 Walgreens Boots Alliance 的目標價從 7.50 美元上調至 8.50 美元，並給予該股票 “表現不佳” 評級。四位股票研究分析師對該股票給予了 “賣出” 評級，七位給予了 “持有” 評級，二位給予了 “買入” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，平均目標價為 10.59 美元。</p>
</div><p><strong>Get Our Latest Report on Walgreens Boots Alliance</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Walgreens Boots Alliance 的最新報告</strong></p>
</div><h2>Walgreens Boots Alliance Price Performance</h2>
<div class="lb-trans"><h2>Walgreens Boots Alliance 價格表現</h2>
</div><ul>
<li>MarketBeat Week in Review – 03/10 - 03/14</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 03/10 - 03/14</li>
</ul>
</div><p>WBA opened at $10.69 on Friday. The firm's fifty day moving average price is $10.73 and its two-hundred day moving average price is $10.05. The company has a market capitalization of $9.24 billion, a price-to-earnings ratio of -1.04, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $18.83.</p>
<div class="lb-trans"><p>WBA 週五開盤價為 10.69 美元。該公司的 50 日移動平均價格為 10.73 美元，200 日移動平均價格為 10.05 美元。該公司的市值為 92.4 億美元，市盈率為 -1.04，市盈增長比率為 1.31，貝塔值為 0.67。該公司的債務與股本比率為 0.68，流動比率為 0.64，速動比率為 0.30。Walgreens Boots Alliance 的一年低點為 8.08 美元，一年高點為 18.83 美元。</p>
</div><p>Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period last year, the company posted $1.20 earnings per share. Walgreens Boots Alliance's quarterly revenue was up 4.1% compared to the same quarter last year. As a group, analysts anticipate that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Walgreens Boots Alliance (NASDAQ:WBA - 獲取免費報告) 最近在 4 月 8 日發佈了季度財報。該藥房運營商報告季度每股收益為 0.63 美元，超出分析師共識預期的 0.53 美元，超出幅度為 0.10 美元。Walgreens Boots Alliance 的股本回報率為 17.61%，淨利潤率為 -5.87%。該公司本季度的收入為 385.9 億美元，而分析師預期為 379.0 億美元。去年同期，該公司每股收益為 1.20 美元。Walgreens Boots Alliance 本季度的收入較去年同期增長了 4.1%。整體來看，分析師預計 Walgreens Boots Alliance 在當前財政年度的每股收益為 1.6 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><ul>
<li>Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>Walgreens Boots Alliance：不要輕易放棄這個資產冠軍</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the stock. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance in the first quarter worth approximately $27,000. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after acquiring an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co raised its stake in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Finally, Colonial Trust Co SC boosted its holdings in shares of Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,297 shares during the period. 58.59% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近調整了對該股票的持有。Sentry Investment Management LLC 在第一季度購買了 Walgreens Boots Alliance 的新頭寸，價值約 27,000 美元。First Financial Corp IN 在第四季度將其在 Walgreens Boots Alliance 的持有量增加了 49.2%。First Financial Corp IN 目前擁有 2,685 股該藥房運營商的股票，價值 25,000 美元，此前在上個季度增持了 885 股。Golden State Wealth Management LLC 在第四季度購買了 Walgreens Boots Alliance 的新頭寸，價值約 26,000 美元。Riverview Trust Co 在第四季度將其在 Walgreens Boots Alliance 的持股增加了 123.8%。Riverview Trust Co 目前擁有 2,874 股該藥房運營商的股票，價值 27,000 美元，此前在上個季度增持了 1,590 股。最後，Colonial Trust Co SC 在第四季度將其在 Walgreens Boots Alliance 的持有量增加了 79.5%。Colonial Trust Co SC 目前擁有 2,928 股該藥房運營商的股票，價值 27,000 美元，此前在此期間增持了 1,297 股。58.59% 的股票由機構投資者持有。</p>
</div><h2>About Walgreens Boots Alliance</h2>
<div class="lb-trans"><h2>關於 Walgreens Boots Alliance</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.</p>
<div class="lb-trans"><p>Walgreens Boots Alliance, Inc 在美國、英國、德國及國際上運營，作為一家醫療、藥房和零售公司。它通過三個部門運營：美國零售藥房、國際和美國醫療。美國零售藥房部門從事零售藥店、健康和保健服務、專業和家庭配送藥房服務的運營，提供健康和保健、美容、個人護理和消費品以及一般商品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Walgreens Boots Alliance</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>Joby Aviation: Operational Momentum vs. Market Sentiment</li>
<li>How Technical Indicators Can Help You Find Oversold Stocks</li>
<li>Broadcom's Big Outperformance Shows Strength Amid Tariff Decline</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>Carvana: Can Turnaround Strength Outdrive Market Headwinds?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Walgreens Boots Alliance</li>
<li>現在購買的 3 只沃倫·巴菲特股票</li>
<li>Joby Aviation：運營勢頭與市場情緒的對比</li>
<li>技術指標如何幫助你找到被低估的股票</li>
<li>博通的強勁表現顯示出關税下降中的韌性</li>
<li>找到並盈利交易 52 周低點的股票</li>
<li>Carvana：能否逆轉強勁的市場逆風？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=WBA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Walgreens Boots Alliance Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Walgreens Boots Alliance 嗎？</h2>
</div><p>Before you consider Walgreens Boots Alliance, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Walgreens Boots Alliance 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而沃爾格林聯合博姿並不在名單上。</p>
</div><p>While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然沃爾格林聯合博姿目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

沃爾格林聯合博姿（NASDAQ:WBA）現在由 StockNews.com 的分析師進行覆蓋